within Pharmacolibrary.Drugs.ATC.G;

model G04BX17
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.041666666666666664,
    adminDuration  = 600,
    adminMass      = 1.0,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sodium salicylate and methenamine is a combination drug formerly used for the treatment of urinary tract infections (UTIs). Methenamine acts as a urinary antiseptic by releasing formaldehyde in acidic urine, while sodium salicylate was used for its analgesic and anti-inflammatory effects. This combination is largely obsolete and is not commonly used or approved for UTI treatment today due to more effective and safer alternatives.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for an adult oral dose in absence of direct published PK models for the combination product.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G04BX17;
